Monday, July 30, 2012

Prescribing Advice for GPs » Drug Safety Update – July 2012

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for July 2012 (PDF).
This issue reminds clinicians of the risk of serious haemorrhage observed with dabigatran (Pradaxa®) and clarifies the contraindications and monitoring requirements.

No comments: